Approaches to simultaneous analysis of frequency and severity of symptoms

Clinical Pharmacology and Therapeutics

Volumn 88, Issue 2, 2010, Pages 255-259

  Plan, E L ^a   Karlsson, K E ^a   Karlsson, M O ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL STUDY; DISEASE SEVERITY; DRUG EFFECT; FREQUENCY ANALYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYMPTOM;

ALGORITHMS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DRUG THERAPY; HUMANS; MODELS, STATISTICAL; NONLINEAR DYNAMICS; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY, CLINICAL; TIME FACTORS;

EID: 77954887396     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.118     Document Type: Article

References (16)

1. Xie, R., Mathijssen, R.H., sparreboom, A., Verweij, J. & Karlsson, M.O. Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea. Clin. Pharmacol. Ther. 72, 265-275 (2002).
2. Bousquet, J. et al. Characteristics of patients with seasonal allergic rhinitis and concomitant asthma. Clin. Exp. Allergy 34, 897-903 (2004).
3. Lunn, D.J., Wakefeld, J. & Racine-Poon, A. Cumulative logit models for ordinal data: a case study involving allergic rhinitis severity scores. Stat. Med. 20, 2261-2285 (2001).
4. Berlin, J.M., golden, S.J., Teets, S., Lehman, E.B., Lucas, T. & Craig, T.J. Efcacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J. Am. Osteopath. Assoc. 100, s8-13 (2000)
5. Gomeni, R., teneggi, V., Iavarone, L., squassante, L. & Bye, A. Population pharmacokinetic-pharmacodynamic model of craving in an enforced smoking cessation population: indirect response and probabilistic modeling. Pharm. Res. 18, 537-543 (2001).
6. Mould, D., Chapelsky, M., Aluri, J., swagzdis, J., samuels, R. & granett, J. A population pharmacokinetic-pharmacodynamic and logistic regression analysis of lotrafban in patients. Clin. Pharmacol. Ther. 69, 210-222 (2001).
7. Yano, I., Beal, S.L. & sheiner, L.B. the need for mixed-efects modeling with population dichotomous data. J. Pharmacokinet. Pharmacodyn. 28, 389-412 (2001).
8. Mandema, J.W. & stanski, D.R. Population pharmacodynamic model for ketorolac analgesia. Clin. Pharmacol. Ther. 60, 619-635 (1996)
9. Sheiner, L.B. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data. Clin. Pharmacol. Ther. 56, 309-322 (1994)
10. Sheiner, L.B., Beal, S.L. & Dunne, A. Analysis of nonrandomly censored ordered categorical longitudinal data from analgesic trials. J. Am. Stat. Assoc. 92, 1235-1244 (1997).
11. Cox, E.H., Veyrat-Follet, C., Beal, S.L., Fuseau, E., Kenkare, S. & sheiner, L.B. A population pharmacokinetic-pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: the antiemetic efect of ondansetron. J. Pharmacokinet. Biopharm. 27, 625-644 (1999).
12. Frame, B., Miller, R. & Lalonde, R.L. Evaluation of mixture modeling with count data using NONMEM. J. Pharmacokinet. Pharmacodyn. 30, 167-183 (2003).
13. Jonsson, E.N. & sheiner, L.B. More efcient clinical trials through use of scientifc model-based statistical tests. Clin. Pharmacol. Ther. 72, 603-614 (2002).
14. Beal, S.L., sheiner, L.B. & Boeckmann, A.J. NONMEM Users Guides, 1989-2006 (Icon Development solutions, Ellicott City, MD, 2006)
15. Sheiner, L.B. & Holford, N.H. Determination of maximum efect. Clin. Pharmacol. Ther. 71, 304; author reply 304-304; author reply 305 (2002).
16. Peck, C.C., Rubin, D.B. & sheiner, L.B. Hypothesis: a single clinical trial plus causal evidence of efectiveness is sufcient for drug approval. Clin. Pharmacol. Ther. 73, 481-490 (2003).